会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Tricyclic antidepressant derivatives and immunoassay
    • 三环抗抑郁药衍生物和免疫测定
    • US06368814B1
    • 2002-04-09
    • US09747809
    • 2000-12-22
    • Mitali GhoshalJane S. C. TsaiStephen Vitone
    • Mitali GhoshalJane S. C. TsaiStephen Vitone
    • G01N33535
    • C07D403/12C07D207/46C07K16/44G01N33/94Y10S436/815
    • The present invention is directed to novel tricyclic antidepressant drug derivatives synthesized for covalent attachment to proteins or polypeptide antigens for use in the preparation of antibodies or receptors to tricyclic antidepressant drugs and tricyclic antidepressant metabolites. The new derivatives are characterized by a saturated double bond on the amitriptyline portion of the molecule and are represented by the structure where R1 is a saturated or unsaturated, substituted or unsubstituted, straight or branched chain of 0-10 carbon or heteroatoms, X is a linker group consisting of 0-2 substituted or unsubstituted aromatic rings, and Y is an activated ester or NH—Z, where Z is a poly(amino acid). The novel tricyclic antidepressant activated hapten derivatives are useful for preparing tracers and conjugates for tricyclic antidepressant immunoassays, including an enzyme immunoassay and a microparticle capture inhibition assay using an antibody produced from the novel immunogen with a conjugate derivatized either at the N-1 position of imipramine or at the C-2 position of dihydroamitriptyline.
    • 本发明涉及用于共价连接蛋白质或多肽抗原的新型三环抗抑郁药物衍生物,用于制备三环抗抑郁药物和三环抗抑郁药代谢物的抗体或受体。 新衍生物的特征在于分子的阿米替林部分上具有饱和双键并且由其中R 1是饱和或不饱和的,取代或未取代的0-10个碳原子或杂原子的直链或支链的结构表示,X是连接基 由0-2个取代或未取代的芳环组成的基团,Y是活化酯或NH-Z,其中Z是聚(氨基酸)。 新型三环抗抑郁药活化的半抗原衍生物可用于制备用于三环抗抑郁药免疫测定的示踪剂和缀合物,包括酶免疫测定和使用由新型免疫原产生的抗体的微粒捕获抑制测定与在丙咪嗪的N-1位衍生的缀合物 或在二氢阿米替林的C-2位置。